Nuper, in Germanico Institutum medicinae et medicinae cogitationes (BFARM) dimisit tertia quartam medical cannabis import data, showing quod in regionem suam scriptor medical cannabis foro est adhuc crescente cursim.
Satus a Aprilis I, MMXXIV, cum exsequendam German Cannabis Act (Cang) et Germanica Medical Cannabis Act (Medcang), Cannabis in Germania Medical Cannabis. In tertia quartam, in Import volumen Medical Marijuana in Germania auctus per LXX% comparari ad priorem quartam (id est prima tres menses post exsequendam Germania scriptor comprehensive Marijuana Reformation). Ut in Germanica medicamenta propellente iam non tracks haec notitia, quod est obscure quot importari medical cannabis medicinae actu intrare pharmacies, sed industria insiders dicunt quod numerus cannabis medicinae etiam augeri cum April.
In tertia quartam de data, in summa import volumen exaruit Cannabis pro medical et medicinae scientia proposita (in kilograms) auctus ad 20,1 talentorum et CXL% ex eodem tempore anni MMXXIV. Hoc est quod totalis import volumen ad primam novem menses huius anni erat 39.8 tons, augmentum 21,4% comparari ad plenam annus Import volumen in MMXXIII. Canada manet in maximae exporter in Cannabis, cum exportantur a LXXII% ((VIII) CXCVIII Exports in maximae Exporter Cannabis, cum Exports per LXXII% ((VIII) XCVIII in exportantur a LXXII% ((VIII) XCVIII et exportantur in maximae exportatoris% ((VIII) XCVIII kilograms in tertia pars ((VIII) XCVIII chilograms in tertia parte ((VIII) XCVIII chilograms in tertia parte ((VIII) XCVIII chilograms in tertia parte ((VIII) XCVIII chilograms in tertia parte ((VIII) XCVIII in exportantur a LXXII% ((VIII) XCVIII chiliograms in tertio. So far, Canada has exported 19201 kilograms to Germany in 2024, exceeding last year's total of 16895 kilograms, which is twice the export volume of 2022. In the past few years, the trend of medical cannabis products imported from Canada dominating in Europe has become increasingly evident, with top Canadian cannabis companies prioritizing exports to the European medical market because prices in the European medical market are more Praeterea comparari princeps tributum domesticis foro. Hoc situ habet litora resistentia ex multa mercatis. In Iulii huius anni, industria media nuntiavit quod post domesticis cannabis effectrix questus de "uber dumping," et Israelis Ministerio in Ianuarii, et Israel est in Canadian Cannabis Ministerium in Canada. Ultima septimana, Israel dimisit ad extremum famam in exitus, revelans ut ad statera pretium pressura pressura de Cannabis in Israel, et imponere a tributum ad CLXXV% in Canadian Medical Cannabis products. Australia Cannabis societates nunc limatura similis uber dumping querelis et dicunt quod invenies eam difficile ad certare in pretio medical canis canada ex Canada. Datum quod foro demanda campester permanere ad fluctuata, est currently seplatum an hoc etiam fiet quaestio Germaniae. Alius magis magis dominatur exporting patria est Portugal. So far this year, Germany has imported 7803 kilograms of medical marijuana from Portugal, which is expected to double from 4118 kilograms in 2023. Denmark is also expected to double its exports to Germany this year, from 2353 kilograms in 2023 to 4222 kilograms in the third quarter of 2024. It is worth noting that the Netherlands, on the other hand, has experienced a significant declinare in export volumen. Ut de tertia quartam de MMXXIV, eius export volumen (MCCXXVII kilograms) est de dimidium de ultimo anno scriptor totalis export volumen MMDXXXVII vehicles.
A clavem proventus ad importers et exporters est ut par ad imperium volumine cum ipsa demanda, ut sunt fere non officialis statistics in quantum Marijuana ad aegris et quanto Marijuana est destrui. Prior ad transitum de German Cannabis Act (Cang), circiter LX% of importari medical cannabis medicamentis cum actu pervenit manus aegris. Niklas Koupperanis, CEO et cooperatores Condita de Karl Germanorum Medical Cannabis Company Bloomwell Group, nuntiavit in media, ut credit hanc proportionem mutantur. The latest data from the German Federal Medical Administration shows that the import volume in the third quarter was 2.5 times that of the first quarter, which was the last quarter before the reclassification of medical marijuana came into effect on April 1, 2024. This growth is mainly due to the improvement of patient drug accessibility, as well as the fully digital treatment methods that are sought after by patients, including remote medical doctor appointments and electronic prescriptions that can be delivered. In notitia ostendi in Bloomwell Platform actually longe excedit ad import data. In Octobris MMXXIV, numerus aegros in Bloomwell Digital Platform et Applications erat XV temporibus, quod Martii hoc anno. Nunc, decem milia aegros accipere curatio omnis mensis per Bloomwell scriptor medical cannabis platform. Nemo scit exigere quantitas provisum est pharmacies quia tunc, ut hoc fama facta outdated post reclassification medicinae Marijuana. Personaliter, credo quod iam non sunt magis quantitates Medical Marijuana reaching aegris. Tamen, maximus factum de German Cannabis industria cum Aprilis MMXXIV fuerit maintaining hoc mirum spargens incrementum sine omni copia shortages.
Post tempus: Nov, 28-2024